FDA Rolls Out Expedited Pilot Program to Address Bottlenecks in Clinical Trials

BioProcess International covers the FDA's new expedited pilot program aimed at clinical trial bottlenecks. The article examines what the pilot is designed to address and why it matters for the pace of drug development.